Cisplatin for cancer therapy and overcoming chemoresistance

Cisplatin spearheads the anticancer chemotherapeutics in present-day use although acute toxicity is its primary impediment factor. Among a plethora of experimental medications, a drug as effective or surpassing the benefits of cisplatin has not been discovered yet. Although Oxaliplatin is considered...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranasinghe, Ranmali, Mathai, Michael L., Zulli, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489975/
https://www.ncbi.nlm.nih.gov/pubmed/36158077
http://dx.doi.org/10.1016/j.heliyon.2022.e10608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489975/
https://www.ncbi.nlm.nih.gov/pubmed/36158077
http://dx.doi.org/10.1016/j.heliyon.2022.e10608

Ejemplares similares